Anticoagulant and membrane-degrading effects of secretory (non-pancreatic) phospholipase A2 are inhibited in plasma

Thrombosis and Haemostasis

Volumn 87, Issue 6, 2002, Pages 978-984

  Billy, Didier ^a   Speijer, Han ^a   Zwaal, Robert F A ^a   Hack, Erik C ^a   Hermens, Wim Th ^a  

^a MAASTRICHT UNIVERSITY   (Netherlands)

Author keywords

Anticoagulation; Ellipsometry; Phospholipase A2; Platelets; Prothrombinase

Indexed keywords

BLOOD CLOTTING FACTOR 10A; BUFFER; FIBRIN; LIPOCORTIN 5; PHOSPHATIDYLSERINE; PHOSPHOLIPASE A2; THROMBIN; THROMBIN INHIBITOR; PHOSPHOLIPASE A; PHOSPHOLIPID;

ANTICOAGULATION; ARTICLE; BINDING KINETICS; BLOOD CLOTTING; COMPARATIVE STUDY; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; DRUG INHIBITION; ELLIPSOMETRY; ENZYMATIC DEGRADATION; ENZYME ACTIVITY; HUMAN; INFLAMMATION; MEMBRANE MODEL; OUTER MEMBRANE; PLASMA CHARACTERISTICS; PRIORITY JOURNAL; PROTEIN DEGRADATION; QUANTITATIVE ANALYSIS; THROMBOCYTE ACTIVATION; BIOLOGICAL MODEL; BIOSYNTHESIS; DRUG ANTAGONISM; DRUG EFFECT; KINETICS; LIPID BILAYER; METABOLISM; PLASMA; THROMBOCYTE; ULTRASTRUCTURE;

BLOOD COAGULATION; BLOOD PLATELETS; FIBRIN; HUMANS; KINETICS; LIPID BILAYERS; MODELS, BIOLOGICAL; PHOSPHATIDYLSERINES; PHOSPHOLIPASES A; PHOSPHOLIPIDS; PLASMA; PLATELET ACTIVATION; THROMBIN;

EID: 0036284586     PISSN: 03406245     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-0037-1613121     Document Type: Article

References (40)

1. Dissection and sequence analysis of phospholipases A2
2. Structure and properties of a human non-pancreatic phospholipase A2
3. Secretory phospholipase A2 is not required for arachidonic acid liberation during platelet activation
4. Serum phospholipase A2 activity and immunoreactivity in a prospective analysis of patients with septic shock
5. A role for secretory phospholipase A2 and C-reactive protein in the removal of injured cells
6. The contribution of bovine factor V and factor Va to the activity of prothrombinase
7. Prothrombin activation on phospholipid membranes with positive electrostatic potential
8. Membrane-mediated assembly of the prothrombinase complex
9. Production of thrombin by the prothrombinase complex is regulated by membrane-mediated transport of prothrombin
10. Platelet procoagulant activity and microvesicle formation. Its putative role in hemostasis and thrombosis
11. Human recombinant non pancreatic secreted platelet phospholipase A2 has anticoagulant activity in vitro on human plasma
12. Determinants of the inhibitory action of purified 14-kDa phospholipases A2 on cell-free prothrombinase complex
13. Inhibition of prothrombinase by human secretory phospholipase A2 involves binding to factor Xa
14. Basic residues of human group IIa phospholipase A2 are important for binding to factor Xa and prothrombinase inhibition
15. A phospholipase A2 with anticoagulant activity. Inhibition of the phospholipid activity in coagulation
16. The basic phospholipase A2 from Naja nigricollis venom inhibits the prothrombinase complex by a novel nonenzymatic mechanism
17. Induction of phospholipase A2 gene expression in human hepatoma cells by mediators of the acute phase response
18. Purification and characterization of a mutant human platelet phospholipase A2 expressed in Escherichia coli
19. Interfacial catalysis by phospholipase A2: Monomeric enzyme is fully catalytically active at the bilayer interface
20. Factor Va-factor Xa interaction. Effects of phospholipid vesicles of varying composition
21. Characterization of two forms of human factor Va with different cofactor activities
22. Therapy with interleukin-2 induces the systemic release of phospholipase A2
23. Changes in membrane phospholipid distribution during platelet activation
24. Critical micelle concentrations and stirring are rate limiting in the loss of lipid mass during membrane degradation by phospholipase A2
25. Circulating levels of secretory type II phospholipase A2 predict coronary events in patients with coronary artery disease
26. Complement activation in patients with sepsis is in part mediated by C-reactive protein
27. Atomic force microscope imaging of phospholipid bilayer degradation by phospholipase A2
28. Formation of supported phospholipid bilayers from unilamellar vesicles investigated by atomic force microscopy
29. Sphyngomyelins in bilayer and biological membranes
30. Lipid polymorphism and the functional roles of lipids in biological membranes
31. Targeting of venom phospholipases: The strongly anticoagulant phospholipase A2 from Naja nigricollis venom binds to coagulation factor Xa to inhibit the prothrombinase complex
32. Relation between various phospholipases actions on human red cell membranes and the interfacial phospholipid pressure in monolayers
33. Human group II 14 kDa phospholipase A2 activates human platelets
34. The nature of the binding site for prothrombinase at the platelet surface as revealed by lipolytic enzymes
35. Secretory phospholipase A2 generates the novel lipid mediator lysophosphatidic acid in membrane microvesicles shed from activated cells
36. A novel phospholipase A2 inhibitor with leucine-rich repeats from the blood plasma of Agkistrodon blomhoffi siniticus
37. Demonstration of a phospholipase A2 inhibitor in human plasma and in plasma from the European hedgehog (Erinaceus europaeus)
38. Determination of a new naphthoquinone derivative, NQ12, in human plasma and urine by high-performance liquid chromatography
39. Antithrombotic and antiplatelet activities of 2-chloro-3-[4-(ethylcarboxy)-phenyl]-amino-1,4-naphthoquinone (NQ12), a newly synthetized 1,4-naphthoquinone derivative
40. Cardiolipin is a normal component of human plasma lipoproteins